33174 Federal Register / Vol. 87, No. 105 / Wednesday, June 1, 2022 / Notices 

1West, CP, Dyrbye, L.N., Satele, D.V, Sloan, J.A., 

& Shanafelt, T.D. (2012). Concurrent validity of 

single-item measures of emotional exhaustion and 

depersonalization in burnout assessment. J Gen 

Intern Med, 27(11 PG–1445–52), 1445–1452. https:// 

doi.org/10.1007/s11606-012-2015-7. 

concern, HRSA informed the 

commenter that the contractor 

conducting the survey would address 

this by issuing each health center a 

document ‘‘in advance of the survey roll 

out that will detail the extensive 

precautions and guarantees regarding 

the collection, storage, use, and 

destruction of the email addresses 

provided, as well as the data security, 

de-identification, and reporting 

aggregation procedures that will be 

utilized to protect the content of the 

responses and the confidentiality of the 

respondents. If a health center has 

remaining concerns that are not 

addressed by those procedures, our 

team will directly discuss alternate 

means by which a tracked and closed 

response could be collected from staff at 

that organization.’’ 

Need and Proposed Use of the 

Information: Health care workforce 

burnout has been a challenge even prior 

to COVID–19 and other recent public 

health crises. Clinicians and health care 

staff have reported experiencing 

alarming rates of burnout, characterized 

as a high degree of emotional 

exhaustion, depersonalization, and a 

low sense of personal accomplishment 

at work.1 Understanding the factors 

impacting workforce well-being and 

satisfaction, reducing burnout, and 

applying evidence-based technical 

assistance and other quality 

improvement strategies around 

workforce well-being is essential as the 

health center program health care 

workforce continues to respond to and 

recover from the COVID–19 pandemic 

and prepare for future health care 

delivery challenges. 

Administration of the Health Center 

Workforce Well-being Survey will 

provide a comprehensive baseline 

assessment of health center workforce 

well-being and identify opportunities to 

improve workforce well-being and 

bolster technical assistance and other 

strategies. These efforts will further 

HRSA’s goal of providing access to 

quality health care and supporting a 

robust primary care workforce. 

Likely Respondents: Health center 

staff in HRSA funded health centers. 

Burden Statement: Burden in this 

context means the time expended by 

persons to generate, maintain, retain, 

disclose, or provide the information 

requested. This includes the time 

needed to review instructions; to 

develop, acquire, install, and utilize 

technology and systems for the purpose 

of collecting, validating and verifying 

information, processing and 

maintaining information, and disclosing 

and providing information; to train 

personnel and to be able to respond to 

a collection of information; to search 

data sources; to complete and review 

the collection of information; and to 

transmit or otherwise disclose the 

information. The total annual burden 

hours estimated for this ICR are 

summarized in the table below. 

TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS

Form name Number of 

respondents 

Number of 

responses per 

respondent 

Total 

responses 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Health Center Workforce Survey ......................................... 400,000 1 400,000 .50 200,000 

Health Center Leader Support Activities ............................. 1,400 1 1,400 2.00 2,800 

Total .............................................................................. 401,400 ........................ 401,400 ........................ 202,800 

HRSA specifically requests comments 

on (1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions; (2) the accuracy of the 

estimated burden; (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2022–11710 Filed 5–31–22; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Establishment of the Office of 

Environmental Justice 

AGENCY: Office of the Assistant 

Secretary for Health, Office of the 

Secretary, Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: The Office of the Assistant 

Secretary for Health (OASH) has 

modified its structure. This notice 

announces the establishment of the 

Office of Environmental Justice in 

OASH’s Office of Climate Change and 

Health Equity. 

DATES: This reorganization was 

approved by the Secretary of Health and 

Human Services and takes effect May 

31, 2022. 

SUPPLEMENTARY INFORMATION: Statement 

of Organization and Functions, Part A, 

Office of the Secretary, Statement of 

Organization and Function for the U.S. 

Department of Health and Human 

Services (HHS or the Department) is 

being amended at Chapter AC, Office of 

the Assistant Secretary for Health 

(OASH), as last amended at 86 FR 

48745, dated August 31, 2021, 75 FR 

53304, dated August 31, 2010, and 72 

FR 58095–96, dated October 12, 2007. 

Background: Executive Order 14008, 

Tackling the Climate Crisis at Home and 

Abroad, directs agencies, including 

Department of Health and Human 

Services to make achieving 

environmental justice part of its mission 

by developing programs, policies, and 

activities to address the 

disproportionately high and adverse 

human health, environmental, and 

climate-related and other cumulative 

impacts on disadvantaged communities. 

This amendment reflects the 

establishment of an office to coordinate 

and provide expertise to support the 

Department’s efforts to protect the 

health of disadvantaged communities 

and vulnerable populations on the 

frontlines of pollution and 

environmental hazards. Specifically, the 

changes are as follows: 

A. Under Part A, Chapter AC, under 

the Office of the Assistant Secretary for 

Health, add the following: 

1. The Office of Environmental Justice 

(OEJ) is headed by a Director who 

reports to the Assistant Secretary for 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 105 / Wednesday, June 1, 2022 / Notices 33175 

Health through the Director of the Office 

of Climate Change and Health Equity. 

2. OEJ shall work with the Immediate 

Office of the Secretary, Staff Divisions, 

and Operating Divisions to focus on: 

• Leading initiatives that integrate 

environmental justice in the HHS 

mission to improve health in 

disadvantaged communities and 

vulnerable populations across the 

nation. 

• Supporting senior leadership at 

OASH and HHS on environmental 

justice and health issues. 

• Developing and implementing an 

HHS-wide strategy on environmental 

justice and health. 

• Coordinating annual HHS 

environmental justice reports. 

• Providing expertise and 

coordination to the White House, 

Secretary of HHS, and federal agencies 

related to environmental justice 

deliverables and activities, including 

executive order implementation. 

• Providing HHS Office of Civil 

Rights with environmental justice 

expertise to support compliance under 

Title VI of the Civil Rights Act of 1964. 

• Promoting training opportunities to 

build an environmental justice 

workforce. 

Xavier Becerra, 

Secretary. 

[FR Doc. 2022–11192 Filed 5–31–22; 8:45 am] 

BILLING CODE 4150–03–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

Research on Current Topics in Alzheimer’s 

Disease and Its Related Dementias. 

Date: June 22, 2022. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Jessica Bellinger, Ph.D., 

Scientific Review Administrator, Center for 

Scientific of Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3158, 

Bethesda, MD 20892, 301–827–4446, 

bellingerjd@csr.nih.gov. 

Name of Committee: Healthcare Delivery 

and Methodologies Integrated Review Group, 

Organization and Delivery of Health Services 

Study Section. 

Date: June 23–24, 2022. 

Time: 9:00 a.m. to 7:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Catherine Hadeler 

Maulsby, Ph.D., Scientific Review Officer, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Bethesda, MD 20892, (301) 435–1266, 

maulsbych@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Collaborative Applications: Decision Support 

for Alzheimer’s Disease and Related 

Dementias (Collaborative R01). 

Date: June 24, 2022. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Catherine Hadeler 

Maulsby, Ph.D., Scientific Review Officer, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Bethesda, MD 20892, (301) 402–2671, 

maulsbych@csr.nih.gov. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 

Sciences Integrated Review Group, 

Pathophysiology of Obesity and Metabolic 

Disease Study Section. 

Date: June 28–29, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Raul Rojas, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6185, 

Bethesda, MD 20892, (301) 451–6319, rojasr@

mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; AREA/ 

REAP: Musculoskeletal, Oral, and Skin 

Sciences. 

Date: June 28, 2022. 

Time: 10:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Carmen Bertoni, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 805B, 

Bethesda, MD 20892, (301) 867–5309, 

bertonic2@csr.nih.gov. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 

Sciences Integrated Review Group, Basic 

Mechanisms of Diabetes and Metabolism 

Study Section. 

Date: June 28–29, 2022. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Liliana Norma BertiMattera, Ph.D., Scientific Review Officer, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

RM 6158, MSC 7890, Bethesda, MD 20892, 

(301) 827–7609, liliana.berti-mattera@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Antiviral 

Drug Discovery and Mechanisms of 

Resistance. 

Date: June 29–30, 2022. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Shinako Takada, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, 301–402–9448, shinako.takada@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

Research on Community Level Interventions 

for Firearm and Related Violence, Injury and 

Mortality (CLIF–VP). 

Date: June 29, 2022. 

Time: 1:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Heidi B. Friedman, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1012A, 

MSC 7770, Bethesda, MD 20892, (301) 379– 

5632, hfriedman@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: May 25, 2022. 

Victoria E. Townsend, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–11649 Filed 5–31–22; 8:45 am] 

BILLING CODE 4140–01–P 


jspears on DSK121TN23PROD with NOTICES1